Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kingdom
September 28, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that an initial one million doses of Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine are now available for use in ...
chat_bubble0 Comment
visibility130 Views
New Mobile Friendly Web Tool With Interactive Dashboard Gives Individuals the Information They Need on Monkeypox in Advance of Attending Gatherings
August 24, 2022
Summer is a time when many of us are keen to get away, enjoy the outdoors and let our hair down at festivals, events and parties. With the monkeypox virus continuing to spread in Europe, ...
chat_bubble0 Comment
visibility159 Views
Gilead Announces First Global Regulatory Approval of Sunlenca® (Lenacapavir), the Only Twice-yearly HIV Treatment Option
August 23, 2022
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted Marketing Authorization for Sunlenca® (lenacapavir) injection and tablets for the treatment of HIV infection, in combination with other antiretroviral(s), in adults with ...
chat_bubble0 Comment
visibility226 Views
Popular Posts
